advertisement

Topcon

Prasanna G 10

Showing records 1 to 10 | Display all abstracts from Prasanna G

79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Adams CM
Pharmaceutical Research 2018; 36: 25
79518 Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells
Lynch JM
Journal of Biological Chemistry 2018; 293: 20137-20156
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Stacy R; Stacy R
Pharmaceutical Research 2018; 36: 25
79518 Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells
Li B; Katoli P
Journal of Biological Chemistry 2018; 293: 20137-20156
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Rangaswamy N; Bigelow C
Pharmaceutical Research 2018; 36: 25
79518 Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells
Xiang C; Leehy B
Journal of Biological Chemistry 2018; 293: 20137-20156
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Grosskreutz CL
Pharmaceutical Research 2018; 36: 25
79518 Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells
Rangaswamy N
Journal of Biological Chemistry 2018; 293: 20137-20156
79741 Glaucoma - Next Generation Therapeutics: Impossible to Possible
Prasanna G
Pharmaceutical Research 2018; 36: 25
79518 Binding of a glaucoma-associated myocilin variant to the αB-crystallin chaperone impedes protein clearance in trabecular meshwork cells
Saenz-Vash V; Wang YK; Lei H; Nicholson TB; Meredith E; Rice DS; Prasanna G; Chen A
Journal of Biological Chemistry 2018; 293: 20137-20156

Issue 20-2

Change Issue


advertisement

Oculus